How can biotech innovators secure the funding they need to create real-world impact?
On 1 October 2026, Hollandbio and the Dutch Biotechnology Association (NBV) will bring together entrepreneurs, investors, policymakers and other stakeholders for the fifth edition of Biotech for a Future-Proof Planet. The event focuses on the financing landscape for biotech innovations in plants, food and biobased materials, and the steps needed to move promising solutions from idea to impact.
Attendees will hear firsthand from biotech entrepreneurs about their fundraising journey and gain insights from both public and private financiers on what they look for when supporting innovative companies. The programme offers practical lessons, inspiring examples and valuable networking opportunities for anyone involved in future-proof biotech innovation.
Supported by ChemistryNL
On Friday 27 November, the LIFE Cooperative is organising LIFE Compliance Day 2026. The day will be entirely dedicated to current compliance issues, knowledge-sharing and networking within our community on the topic of sustainability in medtech.
With more than 3,000 Life Sciences & Health R&D companies, 13 universities, 2,100+ ongoing clinical trials, 104,000+ employees, and an export value of €50 billion, the Netherlands is a major player in the European life sciences industry, boasting a strong technological position in areas such as human vaccines, biopharmaceuticals, and healthcare infrastructure. The Dutch sector owes this position to collaboration, cooperation, and coalition building between companies, research institutes, and universities.
Every year, the LIFE Cooperative attends BIO Europe, bringing together various companies to this global trade fair. BIO Europe Fall connects Europe's leading innovation centers with the global life sciences industry to develop thriving strategic partnerships. Interested in participating or need more information? Fill out the form below!
